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Rapid and Phosphoinositol-Dependent Binding
of the SWI/SNF-like BAF Complex to Chromatin
after T Lymphocyte Receptor Signaling
or nothing is known of the mechanisms that underlie
these rapid, signal-dependent changes in chromatin.
Several chromatin remodeling complexes have been
identified in recent years (for review, see Kingston et
al., 1996 and Kadonaga, 1998). Most of these are related
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sion (Hirschhorn et al., 1992; Cote et al., 1994) in yeast.Duarte, California 91010-0269
The view that SWI/SNF-related complexes function sim-
ilarly in other organisms is supported by the discovery
of the Brahma (Brm) gene in Drosophila, which is 50%Summary
identical to SWI2/ SNF2. Brm mutations suppress poly-
comb mutations and are required for proper develop-Lymphocyte activation is accompanied by visible
mental control of several homeotic genes (Tamkun etchanges in chromatin structure. We find that antigen
al., 1992). Mammalian cells contain at least two genes,receptor signaling induces the rapid association of the
hBRM (Muchardt and Yaniv, 1993) and BRG (Brahma-BAF complex with chromatin. PIP2, which is regulated
related gene) (Khavari et al., 1993), that are closely re-by activation stimuli, is sufficient in vitro to target the
lated to SWI2 and also to Brahma. Both BRG1 and hBRMBAF complex to chromatin, but it has no effect on
are part of independent complexes (Khavari et al., 1993;related chromatin remodeling complexes containing
Wang et al., 1996a), which have nucleosome remodelingSNF2L or hISWI. Purification and peptide sequencing
activity similar to that of the yeast complex (Wang etof the subunits of the complex revealed b-actin as well
al., 1996a). Furthermore, a group of proteins tightly asso-as a novel actin-related protein, BAF53. b-actin and
ciated with BRG1 and hBRM called BAFs (BRG or BrmBAF53 are required for maximal ATPase activity of
associated factors) are related to subunits of the yeastBRG1 and are also required with BRG1 for association
SWI/SNF complex (Wang et al., 1996a, 1996b). The sub-
of the complex with chromatin/matrix. This work indi-
units of the mammalian complex are encoded by gene
cates that membrane signals control the activity of
families. These family members appear to be assembled
the mammalian SWI/SNF or BAF complex and demon-
into the mammalian BAF complex by a combinatorial
strates a direct interface between signaling and chro-
mechanism, giving rise to a diverse group of chromatin
matin regulation. remodeling complexes (Wang et al., 1996a, 1996b). In
addition to the SWI/SNF and BAF complexes, several
Introduction related chromatin remodeling complexes have been
found in higher eukaryotes, including NURF (Tsukiyama
Certain cell types undergo chromatin structural modifi- and Wu, 1995), Chrac (Varga-Weisz et al., 1997), and
cations induced by external stimuli. For example, pe- ACF (Ito et al., 1997) from Drosophila. These complexes
ripheral lymphocytes circulate for many years in a rest- contain ISWI, a subunit that is remotely related to SWI2/
ing, almost spore-like Go state with barely detectable SNF2 but 70% identical to hSNF2L (Elfring et al., 1994).
rates of transcription and protein synthesis. These ªrest- Why so many different chromatin remodeling complexes
ingº cells have small, extremely compact nuclei with are present in higher eukaryotes is unknown.
dense heterochromatin. However, within a few hours While all of the chromatin remodeling complexes ap-
after antigenic activation their nuclei increase 5- to 10- pear similar in their ability to modify nucleosomal struc-
fold in volume and euchromatin appears. These visible ture and allow binding of transcription factors such as
changes in chromatin structure follow the first wave of GAL4 in vitro, it is not yet clear that this is the only or
immediate gene activation in T lymphocytes but precede even the major activity of these complexes in vivo. This
the activation of perhaps a thousand or more genes that view (Lewin, 1994) is inspired by the observation that
take place 16±48 hr after activation (Siebenlist et al., the mammalian SWI/SNF complex is over ten times the
1986; Crabtree, 1989). General and rapid changes of molecular weight of a nucleosome and has two ATPases
chromatin structure also occur in other cell types such and one potential ATPase (Khavari et al., 1993, and this
as sperm, which undergo widespread changes in chro- study). Thus, the complex would be well suited to a
matin structure after entering an egg. At present little highly energetic task that might also make use of the
extensive surface area provided by a protein complex
of 2 MDa. To date, however, the only in vitro assays
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Figure 1. Stimulation of Lymphocytes Re-
sults in Rapid Retention of BAF Complexes
in Nuclei
(A) Mouse lymphocytes were stimulated with
either ionomycin (I) and PMA (P) or anti-CD3
antibody at 378C for 20 min. The nuclei were
isolated and incubated in nuclear buffer at
308C for 1 hr. The solubilized proteins were
separated from the insoluble by pelleting.
Both the supernatant and pellet were re-
solved by SDS-PAGE and immunoblotted
with different antibodies against BAF com-
plex subunits. Since the results were similar
for the other subunits, only the BRG1 blot is
shown. The bands were quantitated by scan-
ning, and the percentage of the BAF com-
plexes retained in the nucleus is listed below
the blots.
(B) Time course of stimulation. Nuclei pre-
pared from mouse lymphocytes stimulated
with I1P for the indicated period of time were
incubated at 308C for 1 hr. The solubilized
and retained BAF complexes were analyzed
as in (A). Only the BAF53 blot is shown, but
each of the BAF subunits becomes associ-
ated with the nucleus. The bands were quan-
titated by scanning, and the percentage of
the BAF complexes retained in the nucleus
is listed below the blots.
(C) Coomassie blue staining of the solubilized proteins from the time course of stimulation in (B).
(D) Same experiment with (B) except blotted against hSNF2L or hISWI.
(E) Ionomycin or PMA stimulation. Lymphocytes were stimulated with ionomycin or PMA at 378C for 20 min and analyzed as in (A).
the rapid changes in chromatin structure following acti- Eukaryotic cells also contain a number of chromatin
remodeling complexes based on hISWI or hSNF2L, avation of lymphocytes, we found that dominant negative
mutations of the BAF57 protein lacking the HMG domain protein similar to SWI2 or SNF2. In contrast to BRG1
and other BAF components, hISWI or hSNF2L remainedbut containing the kinesin domain (Wang et al., 1998)
expressed at physiological levels in T lymphocytes of unassociated with the nucleus during the entire time
course of lymphocyte activation (Figure 1D). Thus, lym-transgenic mice completely block T lymphocyte activa-
tion (Chi et al., unpublished data). However, the lympho- phocyte activation signals selectively affect BAF com-
plexes.cytes of these mice proliferate and survive normally. To
search for the mechanism underlying this striking effect, Lymphocytes require both a Ca21 signal and a PKC/
ras signal for activation. PMA alone, which activateswe have investigated the behavior of the BAF complex
after lymphocyte activation, which we introduce as a PKC, was unable to induce maximal nuclear association
of the BAF complex. Likewise, ionomycin alone, whichuseful model system for study of the mechanisms by
which extracellular signals induce genome-wide chro- opens membrane Ca21 channels, was unable to induce
maximal association of the BAF complex with the nu-matin remodeling.
cleus of murine lymphocytes. However, the combination
of the two was as good as stimulation through the TResults
cell receptor at inducing the association of BAFs with
the nucleus (Figure 1E).The BAF Complex Becomes Stably Associated
with the Nuclei of Lymphocytes within
10 Min of Activation
We reasoned that the rapid chromatin decondensation Phosphatidyl Inositol 4,5-Bisphosphate (PIP2)
Regulates the In Vitro Binding of BAF Complexesthat occurs after engagement of the antigen receptor in
lymphocytes might require the regulated association of to the Nuclear Scaffold/Matrix and Chromatin
To further define the signals necessary for stable associ-one of the known chromatin remodeling complexes with
chromatin or nuclei. In resting murine lymphocytes, ation of the BAF complex with the nucleus we sought
to develop an in vitro assay for nuclear association.about 80%±90% of the BAF complex rapidly leaked out
of isolated nuclei, indicating that the complex is not We found that the BAF complex rapidly leaked out of
digitonin-treated nuclei of resting lymphocytes (Figuretightly associated with the nucleus. However, within 10
min of stimulation with an antibody to the antigen recep- 2A, lane 1), suggesting that adding back signaling inter-
mediates might mediate nuclear association. Additiontor nearly 90% of the BAF complex became tightly asso-
ciated with the nucleus (Figures 1A and 1B). The associ- of PIP2, one of the major mediators of signaling in lym-
phocytes, induced nuclear association of BAF com-ation of other proteins with the nucleus was not changed
by the stimulation, as revealed by Coomassie blue stain- plexes (Figure 2A, lanes 2±4). PIP2 is more effective than
phosphatidylinositol 4-phosphate (PIP) (compare lanesing (Figure 1C).
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have no detectable BRG1 and do not have BAF com-
plexes tightly associated with the nucleus (Figure 2B,
top panel). The distribution of hSNF2L complexes was
not changed by PIP2 treatment (Figure 2B, bottom panel).
Thus, PIP2-dependent targeting was selective for BAF
complexes and not related chromatin remodeling com-
plexes based on hSNF2L.
We found that about 40% of the BAF immunoreactivity
was retained by the nuclear ªmatrix or scaffoldº (Figure
2C, compare lanes 2 and 3), which contains about 5%±
10% of the total cellular DNA. To investigate the possibil-
ity that the BAF complex bound to chromatin associated
with the matrix, the nuclear extracts of Jurkat cells stably
transfected with an HA-tagged BAF57 protein (Wang
et al., 1998) were incubated with permeabilized SW-13
nuclei. Following HCHO cross-linking, chromatin-bound
BAF complexes were then separated from free com-
plexes by CsCl isopycnic centrifugation (Orlando and
Paro, 1993). HA-tagged BAF57 contributed from the Jur-
kat nuclei was then detected with antibodies to HA. PIP2
enhanced the binding of BAF complexes to chromatin
as detected with HCHO cross-linking (Figure 2D). When
only SW-13 nuclei were used for cross-linking, BAF com-
plexes were not found to be chromatin associated as
they were in Jurkat cell nuclei (data not shown). WeFigure 2. PIP2 Is Sufficient to Enhance Binding of BAF Complexes
conclude from these results that the BAF complex inter-to Chromatin and Nuclear Matrix
acts with chromatin in nuclei and this interaction is en-(A) PIP2 enhances the nuclear retention of BAF complexes in lym-
hanced by PIP2.phocytes. Nuclei isolated from mouse lymphocytes were incubated
in nuclear buffer in the presence of 25, 50, or 100 mM of PIP2 (lanes
2, 3, and 4) or PIP (lanes 4, 5, and 6) or without anything (lane
1). The solubilized proteins were separated from the insoluble and The 53 kDa Subunit of the BAF Complex
analyzed as in Figure 1A. The bands were quantitated by scanning, Is an Actin-Related Protein
and the percentage of the BAF complexes retained in the nucleus
Because our studies indicated that some componentis listed below the blots.
of the BAF complex could respond to PIP2-induced(B) PIP2 enhances nuclear binding of exogenous BAF complexes,
signaling, we purified the complex and determined thebut not hSNF2L-containing complexes, to SW-13 cells. Permeabil-
ized SW-13 cells were incubated with Jurkat nuclear extracts at amino acid sequence of the remaining uncharacterized
308C for 30 min in the presence of varying amounts of PIP2. The 53 kDa and 47 kDa subunits of the mammalian SWI/SNF
nucleus-bound proteins were separated from the soluble proteins or BAF complex. Based on the four peptide sequences
and analyzed by Western blotting against BRG1 or hSNF2L.
obtained from the 53 kDa subunit, a cDNA clone encod-(C) PIP2 enhances binding of exogenous BAF complexes to nuclear
ing 429 amino acids was isolated. BAF53 shows exten-matrix. Permeabilized SW-13 cells were incubated with Jurkat nu-
sive homology with actin and actin-related proteins Act2clear extracts at 308C for 30 min in the absence (lane 1) or presence
of 100 mM of PIP2 (lane 2). BAF complexes that bound to SW- and Act3. In addition, after we completed this work, the
13 cell nuclei were analyzed by Western blotting against BRG1. yeast genome project was completed, revealing two
Following incubation of SW-13 cells with Jurkat nuclear extracts, open reading frames in yeast, YPR034w and YMR033w
nuclear matrix prepared by DNase I digestion, and high salt extrac-
(Figure 3A), encoding BAF53 homologs. In addition, antion was analyzed by Western blotting against BRG1 (lane 3). WC,
open reading frame encoding a BAF53 homolog waswhole cell; NM, nuclear matrix.
found in the C. elegans database (Figure 3A). Two out(D) PIP2 enhances BAF complex binding to chromatin. Permeabil-
ized SW-13 cells were incubated with Jurkat nuclear extracts from of three amino acids (Asp11, Gln137, and Asp154 in
a HA-tagged BAF57 cell line at 308C for 30 min in the absence (lane actin) involved in tight Ca21 binding are conserved
1) or presence of 100 mM of PIP2 (lane 2). The cells were cross- (Asp17 and Asp171 in BAF53). In contrast with the over-
linked with formaldehyde and digested with MNase to release chro-
all homology to actin, the ATP-binding pocket in actinmatin. The chromatin purified by CsCl isopycnic centrifugation was
(Kabsch et al., 1990) is poorly conserved in BAF53, sug-resuspended in 23 Laemmli sample buffer and incubated at 658C
gesting that BAF53 may not have ATP binding activityovernight to reverse the cross-linking and analyzed by Western
blotting against the HA-tagged BAF57 subunit of BAF complexes. (additional evidence will be presented in Figure 4A). A
comparison of the sequences of actin family members
(Figure 3B) reveals that BAF53 is most related to Arp3
involved in Listeria motility (Theriot et al., 1994).2, 3, and 4 with 5, 6, and 7). Thus, the ability of phosphoi-
nositols to control the association of BAFs with the nu- To determine the proportion of total cellular BAF53 in
the mammalian complex, we immunoprecipitated thecleus parallels the activity of these signaling inter-
mediates to regulate actin-binding proteins. The nuclear complex with antibodies to several different stoichio-
metric components of the BAF complex. Antibodies toretention of BAF complexes was also enhanced by PIP2
when nuclear extracts from Jurkat cells were incubated BRG1 (Figure 4A, lane 1), BAF170, and BAF57 (data not
shown) immunoprecipitated most of the nuclear BAF53.with nuclei of SW-13 cells, which, as will be shown later,
Figure 3. BAF53 Is an Actin-Related Protein
(A) The mouse and human BAF53 sequences are aligned with human a-actin, human g-actin, yeast actin, and actin-related proteins. The
sequences obtained from the purified BAF complex are underlined in b-actin. The conserved residues that bind calcium and nucleotide are
indicated by arrows.
(B) Dendrogram of BAF53, ARPs, and actins.
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Figure 4. b-Actin Is a Specific Subunit of BAF Complex
(A) Azido-[g-32P]-ATP labels BRG1 and a 48 kDa band. BAF complex was isolated by immunoprecipitation with antibodies against BRG1 as
shown by silver staining in lane 1. The complex was then incubated with azido-[g-32P]-ATP, resolved by SDS-PAGE after irradiation with UV,
and blotted onto a nitrocellulose membrane. The 32P-labeled bands were detected by exposure to X-ray film. The same membrane was used
for Western analysis to identify the labeled bands. Asterisks indicate bands present without nuclear extracts and BAF complexes.
(B) The same assay as in (A) with different antibodies. The IgG heavy chain was nonspecifically labeled because it was in 1000-fold excess
over the BAF subunits.
(C) b-actin is associated with BAF complexes in vivo. Nuclear extracts made from DSP-treated (lanes 1 and 2) or nontreated Jurkat cells were
denatured with 8 M urea and subjected to immunoprecipitation against BRG1. The precipitates were analyzed by Western blotting against
BRG1 and b-actin.
(D) BAF complex binds to cofilin and profilin beads. Nuclear extracts were incubated with glutathione beads bound by the fusion proteins of
cofilin (lane 3), profilin (lane 4), or thymosin b4 (lane 5) with GST or GST alone (lane 2). The beads were washed 3 3 5 min with a buffer
containing 0.5 M NaCl. The bound proteins were resolved by SDS-PAGE, blotted to a nitrocellulose membrane, and detected with BRG1 and
BAF170 antibodies. Five percent of the input was loaded in lane 1.
Depletion of BAFs from Jurkat nuclear extracts with for the immunoprecipitation and azido-ATP labeling ex-
periments (Figure 4B). Actin was coimmunoprecipitatedantibodies to BAF57, BRG1, and BAF150 also depleted
BAF53 (data not shown), suggesting most of the nuclear by all of the antibodies against subunits of the BAF
complex (lanes 1, 2, and 3), but not by antibodies toBAF53 is in the complex.
other nuclear proteins (lanes 4, 5, 6, and 7). To more
rigorously examine the presence of b-actin in the BAFb-Actin Is a Subunit of the BAF Complex
Sequences derived from the lower band of the 47 kDa complex, we used a cell line stably transfected with HA-
tagged BAF57. The HA antibody immunoprecipitateddoublet (Figure 4A, lane 1) proved to correspond to the
previously characterized hSNF5 or Ini protein (Kalpana actin only from the nuclear extracts derived from the HA
BAF57 cell line but not from its parent cell line (compareet al., 1994; Wang et al., 1996a). Purification of the upper
band and determination of six peptide sequences re- lanes 8 and 9 in Figure 4B). Using antibodies to hISWI/
hSNF2L, we found no evidence of actin in these com-vealed that they were all derived from actin (as shown
in Figure 3A): four from the common region of a- and plexes (data not shown).
To determine whether actin is associated with theb-actin and two from the unique region of b-actin. Be-
cause actin is a frequent contaminant in biochemical BAF complex in living cells, we treated living Jurkat cells
with the membrane-permeable, cleavable cross-linkingpurifications, we repeated the purification and sequence
determination. Again all of the peptide sequences were reagent, DSP. Following denaturation in 8 M urea, we
immunoprecipitated with antibodies to BRG1. b-actinderived from actin (data not shown).
To determine whether the actin within the complex was only coimmunoprecipitated from DSP-treated cells,
but not from untreated cells (Figure 4C, compare lanescould bind and hydrolyze ATP, we used azido-g-32P-
ATP, which can be cross-linked to nearby amino acid 2 and 4). In contrast similar cross-linking studies using
the SW-13 cell line, which does not have actin associ-residues by UV irradiation. Two bands from the purified
BAF complex were labeled with 32P after incubation with ated with the complex (see later results), did not reveal
actin (data not shown). These results definitively demon-N3-g-32P-ATP, which was dependent on UV irradiation
(Figure 4A, lanes 2 and 3). The 200 kDa band reacted strate that b-actin is associated with the BAF complex
in vivo and is directly bound to BRG1, since DSP cross-with BRG1 antisera, while the lower band comigrated
with actin and reacted with antibodies to b-actin. The linking is too inefficient to show interactions mediated
by a third protein.bands labeled with the asterisk bound to the beads
nonspecifically. Notably, BAF53 did not bind azido-g- Immobilized BAF complexes did not bind phalloidin
(data not shown); hence, the actin within the purified32P-ATP (Figure 4).
To rule out the possibility that actin was nonspecifi- complex is likely to be a monomer. Quantitation using
specific antibodies to actin revealed that there is aboutcally immunoprecipitated because of its abundance, an-
tibodies to several different BAF components were used one actin molecule per BAF complex and that about 3%
Cell
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Figure 5. Association of BAF53 and b-Actin
with BAF Complex Requires the Presence of
BRG1
(A) The SWI/SNF-like complex in SW-13 cells
does not contain BAF53. The SWI/SNF-like
complex was isolated by immunoprecipita-
tion from SW-13 or Jurkat nuclear extracts
with antibodies against the universal non-
polymorphic subunit, BAF57 (Wang et al.,
1998). The immunoprecipitated proteins were
analyzed by Western blot with antibodies
against different subunits of BAF complex.
SW, SW-13 cells; JK, Jurkat cells.
(B) The SWI/SNF-like complex in SW-13 cells
does not contain b-actin. The SWI/SNF-like
complex was isolated by immunoprecipita-
tion from SW-13 or Jurkat nuclear extracts
with antibodies against BAF57, BAF170, and
BRG1. The proteins were labeled and ana-
lyzed as described in Figure 4A. BAF57 and
BAF170 are shared subunits in the SWI/SNF-
like complexes both in SW-13 cells and in
Jurkat cells. Similar results were seen with
antibodies to b-actin (results not shown).
(C) Introduction of BRG1 into SW-13 cells as-
sembles the b-actin- and BAF53-containing
BAF complex. The different BRG1 constructs were transiently transfected into SW-13 cells by electroporation. Nuclear extracts were made
after 48 hr and were immunoprecipitated with HA antibody (12CA5). The immunoprecipitated proteins were analyzed by azido-[g-32P]-ATP
labeling or Western blot. AS-BRG1, antisense BRG1 construct; BRG1520, BRG1 truncation of 150 amino acid from its C terminus; BRG1095,
BRG1 truncation of 675 amino acid from its C terminus.
of the nuclear actin and about 0.03% of total cellular actin. However, BAF53 was present in SW-13 cells at
levels comparable to those in other cell types (Figuresactin is associated with the BAF complex.
5A and 5B), demonstrating that BAF53 and actin are not
associated with the core complex in SW-13 cells.The BAF Complex Binds the PIP2-Responsive
Actin-Regulatory Proteins, Cofilin, The above observations suggest that the association
of actin and BAF53 with the complex may require theand Profilin
The many cellular functions of actin are regulated by presence of BRG1. To test this possibility, we trans-
fected an HA-tagged BRG1 expression vector into SW-small actin-binding proteins such as profilin and cofilin
that are in turn regulated by PIP2 (Goldschmidt-Cler- 13 cells, then immunoprecipitated with HA antibodies
to determine whether BRG1 could mediate the assemblymont et al., 1990; Theriot et al., 1994). If actin were a
functional component of the BAF complex, one would of b-actin and BAF53 into the BAF complex. BAF53 and
actin were specifically immunoprecipitated with HA anti-predict that it would interact with PIP2-responsive actin-
regulatory proteins, such as profilin and cofilin. As shown bodies only with transfection of BRG1 but not antisense
BRG1 (compare lanes 1 and 2 of Figure 5C). C-terminalin Figure 4D, BAF complexes bound to profilin and cofi-
lin, coupled to beads (lanes 3 and 4), but no binding deletion of 150 amino acids from BRG1 severely com-
promised assembly of the complex (lane 3), while trun-was detected to GST or thymosin b4 beads (lanes 2 and
5). The BAF complex also specifically bound to DNAse cation, which removed half of the ATPase domain, abol-
ished complex assembly, leaving some actin still boundI, which binds actin (data not shown). Since profilin and
cofilin bind to domains 1 and 3 on the barbed end of to the complex (lane 4). We conclude that BRG1 is re-
quired in vivo to support the assembly of actin andactin (Schutt et al., 1993; Hatanaka et al., 1996), these
results indicate that these domains would be available BAF53 into the BAF complex.
for the BAF-associated actin to bind to actin-regulatory
molecules.
b-Actin and BAF53 Directly Interact with BRG1
in the BAF ComplexAssociation of Actin and BAF53 with the Complex
Requires BRG1 The observation that BRG1 was required for actin and
BAF53 to associate with the BAF complex led us toTo define the components of the BAF complex that are
essential for chromatin association, we made use of the determine whether these subunits directly interact. After
treatment of Jurkat nuclear extracts with 5.5 M urea forSW-13 cell line. The SW-13 cell line contains no detectable
hbrm or BRG1 proteins, but nonetheless contains a BAF- 30 min at 258C, actin but none of the other subunits
was coimmunoprecipitated with BRG1 by anti-BRG1 (forlike complex without BRG1 or hbrm (Muchardt and Ya-
niv, 1993; Dunaief et al., 1994). BAF57 antibodies immu- silver staining see Figure 6A, lane 1, and for Western blot
see Figure 6B). Although two other bands are presentnoprecipitated a ªcore complexº from SW-13 nuclear
extracts that contains most subunits but not BAF53 or on the silver-stained gel (Figure 6A, lane 1), they are
Regulation of the BAF Complex by Signaling
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Figure 6. b-Actin and BAF53 Directly Interact
with BRG1 in BAF Complex
(A) BAFs interact with BRG1 with different
affinity. Jurkat nuclear extracts were partially
denatured with 5.5 M urea following DSP
treatment and subjected to immunoprecipita-
tion against BRG1. The immunoprecipitates
were analyzed by SDS-PAGE and silver stain-
ing. Note that b-actin resisted 5.5 M urea de-
naturation, and BAF53 was directly cross-
linked to BRG1. Asterisks indicate bands
present without nuclear extracts and BAF
complexes.
(B) The Jurkat nuclear extracts were treated
with 5.5 M or 8 M urea before immunoprecipi-
tation using BRG1 antibodies. The coprecipi-
tated proteins were analyzed by Western blot
with antibodies against different subunits of
BAF complex.
(C) Western blot analysis of immunoprecipi-
tates against BRG1 following DSP and 5.5 M
urea treatment. The Jurkat nuclear extracts
were treated with DSP before treatment with
5.5 M urea. The immunoprecipitated pro-
teins with BRG1 antibodies were analyzed by
Western blot with different antibodies.
substoichiometric and thus unlikely to mediate an inter- The Actin Monomer Sequestering Natural Product,
Latrunculin B, Blocks Chromatin-Dependentaction between BRG1 and actin. Hence, actin and
BRG-1 are likely to directly interact. To test this possibil- ATPase Activation of the BAF Complex
Since actin appears to directly interact with BRG1, weity more carefully, we first briefly treated Jurkat nuclear
extracts with DSP and then partially denatured with urea. examined whether actin affected the rate of ATP hydro-
lysis by BRG1 by using latrunculin B (LB), a well-charac-Under these conditions both actin and BAF53 were
found to coimmunoprecipitate with BRG-1 (Figure 6A terized molecule that specifically inhibits the actions of
actin by sequestering actin monomers (Coue et al.,and 6C). These experiments demonstrate that actin and
BAF53 directly interact with BRG1 in the BAF complex 1987). Binding of BAF to DNA or chromatin resulted
in a substantial increase in the ATPase activity of thein vitro, since the cross-linking was sufficiently ineffi-
cient to detect interactions mediated by a third protein. complex (Figure 8A, lanes 1, 2, and 3). Addition of 600
mM LB completely blocked the DNA or chromatin-
induced increase in ATPase activity of the complex (Fig-Introduction of BRG1 into BRG1-Deficient Cells
ure 8A, lanes 4, 5, and 6) but had only minor effects onInduces Stable Association of BAF53
the background nonstimulated ATPase activity (Figureand Actin with Chromatin/Nuclear Matrix
8A, compare lanes 1 and 4). Cytochalasin D, which bindsNuclear fractionation experiments revealed that the BAF
to the barbed ends of actin filaments and prevents fila-complex was stably associated with the nuclear matrix
ment growth, did not have a significant effect on thein HeLa cells, which has the BRG1-, BAF53-, and
stimulated or basal ATPase activity (Figure 8A, lanes 7, 8,b-actin-containing ªcompleteº complex, but not in SW-
and 9). These results are consistent with the observation13 cells that contain a complex lacking BAF53, actin, and
that actin is likely to be a monomer in the complex.BRG1 (Figure 7A). Furthermore the ªcompleteº complex
Latrunculin B was not simply inhibiting the ATPase activ-from Jurkat cells binds stably to the nuclei of SW-13 cells
ity of BRG1 because neither the basal level ATPasein an in vitro assay (Figure 2B), raising the possibility
activity of the BAF complex nor the ATPase activity ofthat stable association of the complex with the nucleus
the isolated ATPase domain of BRG1 was affected byrequired BRG1, BAF53, and b-actin. To test this possibil-
latrunculin B (Figure 8A, compare lanes 10, 11, and 12).ity, we prepared nuclear matrix/chromatin from SW-13
Furthermore, the ATPase activity of complexes basedcells transiently transfected with HA-tagged BRG1 and
on hSNF2L was not inhibited by latrunculin B (data notdetermined whether the complex is retained in the nu-
shown).clear matrix/chromatin in the absence and presence of
The BAF complex contains two ATP-binding subunits,BRG1 by double immunostaining. Whole-cell staining
actin and BRG1, as shown in Figure 4A. To distinguishdemonstrated that BRG1 (red) was detected only in
between the possibility that latrunculin B directly inhib-transfected cells, while BAF57 (green), which is in the
ited the actin ATPase versus the possibility that actinSW-13 complex, and BAF53 (green), which is not in the
is required to enhance the BRG1 ATPase activity, weSW-13 complex, were detected in the nucleus of every
measured the ATPase activity of the actin subunit in thecell (Figure 7B). However, the BAF57 and BAF53 signals
complex. This was done by covalently cross-linking N3-were only detected in the nuclear matrix preparations
g-32P ATP to its binding site in actin in the pure complexwhere BRG1 was detected (Figure 7B, panels labeled
NM). We conclude that the assembly and stable associa- so that the 32P would not be lost unless hydrolyzed. As
shown in Figure 8B, the 32P label was gradually losttion of the complex with the nuclear matrix/chromatin
requires BRG1, BAF53, and b-actin. during incubation, suggesting that the ATP bound to
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an upper limit. The overall ATPase activity of the BAF
complex was measured according to Laurent et al.
(1993) and Cote et al. (1994) and found to be about
350 mol/mol.hr at 378C. Therefore, the b-actin subunit
contributes about 1% of the overall ATPase activity of
BAF complex in vitro. Furthermore, the ATPase activity
of b-actin was not stimulated by DNA or chromatin (data
not shown). These results indicate that Latrunculin B
blocks the activated ATPase activity of the BAF complex
by interfering with the actions of actin on the ATPase
activity of BRG1.
The Actin Subunit Is Required for Optimal
ATPase Activity of BRG1
To provide independent evidence that actin and BAF53
regulate the ATPase activity of BRG1, we purified a
subcomplex containing BRG1, BAF53, and b-actin by
immunoprecipitation with the BRG1 antibody following
treatment of Jurkat nuclear extracts with 5 M urea at
258C for 10 min (Figure 8C, lanes 3 and 4). For compari-
son, BRG1 alone was prepared using a 10 min wash of
immunopurified intact complex at 258C with 5 M urea,
which dissociated all the subunits including BAF53 and
b-actin (Figure 8C, lanes 5 and 6). BAF250 and 60 (Wang
et al., 1996b) were also removed as determined by silver
staining (data not shown). The BRG1, BAF53, and actin
subcomplex retained about 20% of the ATPase activity
of the intact complex (Figure 8D, compare lanes 1 and
3). However, when b-actin and BAF53 were removed,
the ATPase activity dropped to only 2% (Figure 8D,
compare lanes 1 and 5). The ATPase activity of the
subcomplex was not due to the ATPase activity of actin,
since actin contributes only about 1% of the total ATPase
activity of the intact complex (Figure 8B). Further-
more, similar amounts of purified actin did not result in
significant ATP hydrolysis under the conditions used to
assay SWI/SNF or BAF complex ATPase activity (data
not shown). The reduced activity of BRG1 alone as com-
pared to the BRG1, BAF53, and actin subcomplex was
not due to urea denaturation, since both were exposed
to 5 M urea and this treatment was not sufficient to
interfere with the BRG1±antiBRG1 interactions neces-
sary to maintain the complex on beads. The ATPase
activity of the BRG1, BAF53, and actin subcomplex was
Figure 7. BRG1 and Actin Subunits Are Required for BAF Complex not stimulated by DNA (Figure 8D, lanes 3±6), suggesting
Association with the Nuclear Scaffold or Matrix
that a DNA-binding subunit (such as BAF57) is neces-
(A) The nuclear scaffold or matrix preparation from HeLa and SW-
sary for contacting DNA and stimulating ATPase activity.13 cells was resolved by SDS-PAGE, blotted onto a nitrocellulose
membrane, and detected with different antibodies. The intensity of
the band with the Lamin B1 antibody is shown to reflect the number Binding of Actin and BAF53 to BRG1
of nuclei present in the sample. WC, whole cell; NM, nuclear scaffold
Requires In Vivo Coassemblyor matrix.
The ability to prepare isolated BRG1 protein led us to(B) Transfection of BRG-1 into SW-13 cells results in the stable
carry out two additional tests to determine whether actinassociation of b-actin- and BAF53-containing complexes with the
nuclear scaffold or matrix. Either whole-cell (WC) or scaffold/nuclear could nonspecificially associate with the BAF complex.
matrice (NM) prepared from SW-13 cells transiently transfected with In the first we added back the SW-13 nuclear extract
BRG1 were immunostained and double-labeled with red (BRG1) and containing free BAF53 and b-actin to the isolated BRG1
green (BAF57 or BAF53).
protein beads (Figure 8C, lanes 5 and 6). We found no
evidence of BAF53 or b-actin binding to the BRG1 beads
under conditions that readily detected both actin andactin was hydrolyzed, most likely by the ATPase activity
of actin itself. The rate of release of [32P]Pi was 3 mol/ BAF53 using extracts from a variety of cell types (data
not shown). In the second approach we cotranslatedmol.hr at 378C in the first 10 min of incubation. Since
the nucleotide exchange rate was not considered, this these subunits in a rabbit reticulocyte lysate and immu-
noprecipitated with the J1 anti-BRG-1 antibody. Againestimation of actin ATPase activity in the complex is
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Figure 8. The Actin Subunits Are Required
for the ATPase Activity of BRG1
(A) Latrunculin B inhibited the chromatin-
stimulated ATPase activity of the BAF com-
plex. In lanes 1±9, affinity-purified BAF com-
plex (1 mg) was assayed for ATPase activity
in the presence (1) or absence (2) of DNA
or chromatin (chr) with 600 mM latrunculin B
(L.B.) or 200 mM cytochalasin D (C.D.). After
30 min incubation, the products were ana-
lyzed by TLC and quantitated by scanning.
In lanes 10±12, 1 mg of the BRG1 ATPase
domain (aa 735±1443) expressed in Pichia
was assayed and analyzed similarly.
(B) The actin subunit of BAF complex hydro-
lyzes ATP. Azido-[g-32P]-ATP was cross-
linked to purified BAF complex by UV irradia-
tion as described in Figure 3A and incubated
in reaction buffer for the indicated period of
time before stopping the reaction by addition
of SDS sample buffer. The proteins were re-
solved by SDS-PAGE, blotted onto mem-
brane, and exposed to X-ray film. The radio-
activity in the actin band was quantitated and
listed under the figure.
(C) Western blot of 5 M urea-treated complex.
Lanes 1 and 2, intact BAF complex purified
with antibodies against BRG1; lanes 3 and 4,
immunoprecipitates against BRG1 following
5 M urea treatment of nuclear extracts; lanes
5 and 6, complex purified as in lanes 1 and
then washed with 5 M urea for 10 min at room
temperature.
(D) The different immunoprecipitates de-
scribed in (C) were assayed for ATPase activ-
ity in the presence or absence of DNA. The
products were analyzed by TLC and quanti-
tated by phosphorimage.
no evidence of coimmunoprecipitation was found under mammalian BAF53 cDNA, the yeast genome project re-
vealed two yeast homologs of BAF53 (YPR034W andconditions where anti-BRG1 antibodies coimmunopre-
cipitated both actin and BAF53 from cell extracts (data YMR033W). Peptide sequences of the yeast homologs
of BAF53 were identified from the purified yeast SWI/not shown). These results suggest that the tight interac-
tion between BRG1, actin, and BAF53 is established SNF complex by Cairns and Kornberg. Null mutations
in this gene have a phenotype similar to the phenotypethrough molecular chaperones in vivo and could not
have occurred during preparation of extracts or mixing of mutations in the SWI/SNF genes (B. Cairns and R.
Kornberg, unpublished data).of nuclear and cytoplasmic components.
The existence and function of nuclear actin has been
in question for a number of years. Our results demon-Discussion
strate that in excess of 90% of SWI/SNF complexes,
but not related chromatin remodeling complexes basedb-Actin and the Actin-Related Protein BAF53
Are Subunits of BAF Complexes on hISWI, have tightly associated b-actin. One role of
this actin is to participate with BAF53 and BRG1 in theThe following lines of evidence support the conclusion
that b-actin and the actin-related protein BAF53 are association of the complex with nuclear matrix/chroma-
tin. A second role is to enhance ATPase activity of BRG1.functional subunits of the BAF complex: (1) they specifi-
cally coimmunoprecipitate at physiological concentra-
tions with all available antibodies against BAF subunits
A Model for the Regulation of the mSWI/SNFeven under very stringent conditions; (2) they associate
or BAF Complex by Membrane Signalingwith the complex only in the presence of BRG1; (3) they
Our studies indicate that signals from the lymphocytedirectly interact with BRG1 in the complex by two inde-
antigen receptor regulate chromatin remodeling by reg-pendent biochemical criteria; (4) actin can be specifically
ulating PIP2 levels that in turn control the associationcovalently cross-linked to BRG-1 in living cells using
of the complex with chromatin or some component ofbifunctional cross-linking agents that do not detect in-
nuclear matrix. A likely role for PIP2 is to control theteractions mediated by a third protein; and (5) they are
actions of actin in the BAF complex by regulating therequired for the maximal ATPase activity of BRG1. Addi-
function of a nuclear actin-binding protein.tional support for our conclusion that BAF53 is a func-
PIP2 directly regulates actin function by displacingtional component of the complex comes from the iden-
tification of a yeast homolog. After isolation of the actin-binding proteins from actin (Janmey and Stossel,
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nuclear retention assay was performed as described (Reyes et al.,1987; Yu et al., 1990). For most actin-binding proteins
1997). The released proteins were separated from nuclei by centrifu-this would require that domains 1 and 3 of actin be
gation, and both the supernatant and pellet were analyzed by SDS-exposed in the BAF complex, which is the case since
PAGE according to Laemmli (1970) and Western blot. For the phos-
both profilin and cofilin bind to actin within the complex. photidylinositol phosphate experiments, the nuclei isolated from
The role of actin in targeting the complex is supported nonstimulated lymphocytes were incubated in the presence of PIP2
or PIP from homogeneous micelles prepared as previously de-by the observation that BRG1, BAF53, and actin are
scribed (Goldschmidt-Clermont et al., 1990).required for association of the BAF complex with the
nuclear matrix/chromatin in SW-13 cells, which have a
Immunoprecipitation of the BAF Complexcomplex that lacks these three subunits. This model
after In Vivo Cross-Linkingrequires that PIP2 and PI4-phosphate 5-kinase, which
Jurkat cells (1 3 108) were cross-linked with 0.5 mM dithiobis-succin-is the enzyme that responds to rho family GTPases and
imidylpropionate (DSP) for 10 min at room temperature, and nuclear
regulates PIP2 synthesis (Chong et al., 1994; Hartwig et extracts were made as described previously (Wang et al., 1996a).
al., 1995), be present within the nucleus. This is in fact The nuclear extract (200 ml) was precipitated with (NH4)2SO4 (final
the case, and a large proportion of both PIP2 and PI concentration 35%) and denatured by resuspending the pellet in 8
M urea. The denatured nuclear extracts were diluted 10-fold in RIPA4-phosphate-5 kinase are present in the nucleus (Di-
buffer (10 mM Tris/Cl [pH 7.4], 1 mM EDTA [pH 7.4], 300 mM NaCl,vecha et al., 1993; Divecha and Irvine, 1995). Further-
1% Triton X-100, 0.1% SDS, 0.1% sodium deoxycholate, 1 mM DTT,more, the beta-isoenzyme of phospholipase C, which
1 mM PMSF) and immunoprecipitated with antibodies to BRG1. The
hydrolyzes PIP2, is found on the nuclear scaffold or cross-linking was cleaved by boiling the sample in 23 Laemmli
matrix (Mazzotti et al., 1995). Although changes in PIP2 sample buffer for 10 min, and proteins were analyzed by SDS-PAGE
in response to lymphocyte signaling have not been stud- and Western blot.
ied, when Friend cells are induced to differentiate, nu-
clear PLCb activity is reduced, accompanied by a signifi- Azido-(g-32P)-ATP Labeling
The BAF complex beads (10 ml) were incubated with 2 mCi ofcant increase of nuclear PIP2 (Billi et al., 1993). The
8-azidoadenosine 59-[g-32P] triphosphate for 3 min at room tempera-increase in nuclear PIP2 would be expected to displace
ture in 15 ml of buffer containing 20 mM HEPES (pH 7.6), 100 mMactin-binding proteins from actin in the BAF complex.
KCl, 5 mM MgCl2, 1 mM ZnSO4, 1 mM DTT, and 0.1% Tween 20.While substantial data support each of these steps, de- The reaction mixture was irradiated for 3 min using a short-wave
finitive evidence for this model will require purification UV light. The beads were washed immediately twice with 1 ml of
of the proposed nuclear PIP2-responsive nuclear actin the reaction buffer without MgCl2 and ZnSO4. After elution with 23
SDS sample buffer, the labeled proteins were resolved by SDS-regulatory protein(s) and biochemical add back experi-
PAGE, blotted to nitrocellulose membrane, and exposed to X-rayments using purified BAF complexes.
film. For the actin ATPase assay, the UV cross-linked beads wereThe observation that the mSWI/SNF or BAF complex
incubated at 378C in the reaction buffer for different times before
becomes stably associated with chromatin within 10 elution and SDS-PAGE analysis.
min of antigen receptor stimulation strongly indicates
that neither protein synthesis nor new gene activation
ATPase Assay
is required for targeting the complexes, since no de- The intact BAF complex was purified by immunoprecipitation with
tectable increase in transcription or protein synthesis is affinity-purified BRG1 antibodies after diluting Jurkat nuclear ex-
tracts 103 in RIPA buffer. For purification of the BRG1-actin-BAF53-seen before this time (Crabtree, 1989). At present little
containing subcomplex, the Jurkat nuclear extracts were adjustedis known of how external stimuli lead to rapid chromatin
to 5 M urea and incubated for 10 min 258C. The partially denatureddecondensation. Our findings that BAF complexes are
nuclear extracts were diluted 103 in RIPA buffer and immunoprecip-capable of chromatin remodeling in vitro (Wang et al.,
itated with BRG1 antibodies. To dissociate b-actin, BAF53, and other
1996a), contain actin and actin-related proteins, and BAF subunits from BRG1, the immunopurified intact BAF complex
are rapidly targeted to chromatin and the nuclear scaf- beads were washed with RIPA buffer containing 5 M urea 2 3 5
min at 258C. All the immunoprecipitations were done at 48C for 4fold or matrix by a PIP2-dependent mechanism define a
hr, and the immunoprecipitates were washed for 4 3 10 min eachdirect interface between chromatin regulation and signal
in RIPA buffer.transduction. While actin is a likely candidate to mediate
The ATPase domain of BRG1 was expressed and purified withthe targeting of BAF complexes to chromatin/nuclear
the Invitrogen EasySelect Pichia expression kit, as a His-tag fusion
matrix, additional studies will be essential to demon- protein.
strate this directly. The ATPase activity of the BAF complex was measured according
to published procedures (Laurent et al., 1993). The released Pi from
ATP hydrolysis by the BAF complex was determined as describedExperimental Procedures
(Cote et al., 1994).
Purification and cDNA Cloning of BAF53
BAF53 was purified by isolating the BAF complex from calf thymus Transient Transfection
nuclear extracts by conventional and immunoaffinity chromatogra- SW-13 cells were maintained and transfected as described pre-
phy as described previously (Wang et al., 1996a). viously (Wang et al., 1996a).
The 48 kDa subunit of the BAF complex was originally isolated
from rat liver nuclear extract and sequenced by Edman-degradation
Nuclear Scaffold or Matrix Preparation and Immunostainingmethod. All three tryptic peptide sequences match actin (data not
The nuclear scaffold or matrix was prepared and immunostainedshown). The subunit was also isolated from human KB cells and
according to van Steensel et al. (1995).analyzed by electron spray mass spectrometry.
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